The nationwide rollout and expansion of the HeartRisk platform into new markets such as correctional facilities and risk-bearing providers represents a significant growth opportunity for Cardio Diagnostics Holdings, Inc. This strategic move not only diversifies the application of their technology but also opens up new revenue streams. The innovative approach of combining AI with clinical and geographic data to provide actionable insights is likely to be well-received, potentially leading to increased adoption and positive market reception. This expansion could significantly enhance the company's visibility and position it as a leader in precision cardiovascular medicine, likely resulting in a positive short-term impact on its stock price.